SEC Form 4 · accession 0001193125-26-292644
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kyle Guse
Director
Period of report
Jul 1, 2026
Accepted (ET)
Jul 1, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001095981
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Jul 1, 2026 | M | 922 | $0.00 | A | 922 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2 | $0.00 | Jul 1, 2026 | M | 922 | D | — | — | Common Stock | 922 | 2,764 | D |
Explanation of responses
- F1Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.
- F2Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026.